Tag Archive | "cent-and"

Tags: , , , , , , , , , , , , , , , , , , , , , , , ,

Allana Potash Corp – ALLRF


Allana Potash Corp. Is a publically traded company with a focus on the exploration and development of its potash assets. The company’s flagship asset ( encompassing approximately 312 km²) is its Ethiopia Potash Project in the Danakhil evaporite basin in the Dallol region of Afar province in the northeastern part of the country (please see the map below).

Allana has delineated the following Proven and Probable Sylvinite Reserves at Danakhil*:

RESERVE CATEGORY

POTASH MEMBER

MINEABLE TONNES (MT)*

KCl(%)

MOP (MT)

PROVEN

Sylvinite

32.97

28.0

8.2

PROBABLE

Sylvinite

60.81

28.8

15.5

Total

23.7

Allana has delineated the following Measured and Indicated Mineral Resources at Danakhil*:

CATEGORY

POTASH MEMBER

IN-SITU TONNAGE (MT)*

KCl(%)

CONTAINED KCl (MT)

MEASURED

Sylvinite

115.3

27.8

32.1

Upper Carnallitite

121.5

17.5

21.3

Lower Carnallitite

235.0

9.7

22.8

Kainitite

552.3

19.2

105.9

Total

1,024.1

17.8

182.1

INDICATED

Sylvinite

212.1

28.6

60.7

Upper Carnallitite

289.8

17.2

49.9

Lower Carnallitite

322.2

8.9

28.7

Kainitite

598.2

19.5

116.8

Total

1,422.3

18.0

256.1

Allana has also delineated additional Inferred Mineral Resources (see Projects section)*.

(The foregoing mineral resource and reserve estimates are as at April 17, 2013)*.*Please refer to the Legal Disclaimer section below for important information regarding Resource and Reserve estimates.

Allana also has potash claims (over 1540 square km) under application in Argentina ( in Neuquen province) adjacent to Vale’s Rio Colorado potash project.

Allana Potash trades on the TSX under the symbol AAA. It has approximately 325.1 million common shares(basic) outstanding as of April 1st, 2014.

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

PuraMedBioScience™


Mission

PuraMed BioScience®, Inc., is a pharmaceutical company specializing in the research, development, and marketing of safe, highly effective, non-prescription medicinal and healthcare products with the purpose of reaching and improving the quality of life for underserved populations in the OTC marketplace.

By applying hard science to natural products, PuraMed BioScience is committed to the establishment of a leadership position in the OTC natural and alternative health remedy market by introducing a safe and effective product line” that delivers better performance with fewer side effects than its chemical counterparts.

PuraMed BioScience recently formed a new division within the company to research, develop, and distribute a line of products incorporating hemp-derived cannabinoids as key components. The company plans to launch additional cannabinoid-enhanced, anti-inflammatory and anxiolytic products as it moves forward in the development of its CBD product line.

PuraMed BioScience, Inc., employs the use of double-blind placebo controlled testing to establish efficacy and safety benchmarks for products made with natural ingredients. Using this information, PuraMed BioScience directs marketing efforts directly to the consumer, retail, and product-related patient populations.

LipiGesic M, PuraMed’s flagship formulation, is a homeopathic medication using feverfew and ginger delivered sublingually (under the tongue) for the relief of migraine pain and associated symptoms. This initial product from the company has been clinically tested and featured in three (3) top-tier medical journals with articles authored by America’s leading migraine headache experts.

Based on the results of the clinical trials, LipiGesic M has an efficacy that is comparable to the top-selling triptan medication. However, LipiGesic M has an excellent safety profile, is non-drowsy and has no reported interactions with other medications. With this initial product, PuraMed BioScience has met the criteria the company set to create a superior natural product that works better than its chemical counterpart in the resolution of migraine pain and associated symptoms.

About the Company

PuraMed BioScience was established to capture two unique opportunities. The first is to build a substantial and profitable business with the distribution of LipiGesic® M a formulation created for the acute relief of migraine headaches. PuraMed BioScience is also reviewing several third-party health and wellness products that can be incorporated into the company’s product offering. Each of these is effective and addresses a very large OTC consumer market, collectively well over $2 billion in the U.S. Each product will be unique in its class.

The second, longer-term, opportunity is to establish a leadership position in the highly fragmented OTC natural and alternative-health remedy market by introducing a “new kind of product line.” The PuraMed BioScience product line will consist of ‘alternative’ remedies for common ailments. With effective messaging campaigns, these products have the potential to be adopted by the majority, many of whom prefer ‘natural’ alternatives, provided there is no need to sacrifice performance or convenience.

Company Management

Each member of the PuraMed BioScience management team brings decades of experience needed to compete in the over-the-counter and alternative health industry. This experience includes product development, drug formulation, direct marketing, sales, regulatory compliance and approval, and senior management of both public and private companies.

Business Strategy

PuraMed BioScience® Inc., intends to execute according to the following seven-step strategy.

1. Identify effective products with large market opportunities.

2. Employ a unique and effective delivery system.

3. Perform clinical trials and obtain clinical results to overcome consumer skepticism.

4. Employ a direct-response sales campaign to refine the consumer message and generate initial revenue.

5. Achieve broad, retail distribution to provide easy and widespread consumer access.

6. Apply effective marketing to drive consumer awareness and the buying impulse.

7. Capture “first-mover” advantage.

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

DC Brands International Inc – HRDN


Company History

  • Started in 2004 as an Energy Drink Company
  • Dickens Energy Cider
  • Turn Left Energy Drink
  • In 2007 entered the Nutritional Beverage Space – Hard Nutrition
  • Functional Water System: Nine Functions
  • Weight Loss
  • 5 Hours Mental Acuity
  • Full Body Cleanse
  • Hangover Relief
  • Pre & Post Workout
  • 10 Hours All Natural Energy
  • Daily Vitamins
  • In 88 King Sooper’s (Kroger Brand) Grocery Stores along Front Range of Colorado
  • Lost Funding Jan 2013 began restructuring
  • Purchased 15% of Village Tea Company – New York Based Premium loose leaf tea.
  • April 2014 – Announced entry into Colorado Marijuana Industry
  • June 2014 – Signed contract with 1st Client

Colorado Marijuana Industry

  • 2000 Medical Marijuana approved
  • JAN 2014 Recreational Marijuana Sales Began
  • Approximately 500 licenses issued originally
  • In 2014 approximately 225 licenses canceled due to regulatory issues
  • Company’s opinion is regulators are trying to move out the small operators/stoners and get the larger operators/business people involved

Dc Brands Green Investments, Llc Value Proposition

  • Green will offer a bundle of services to Colorado Marijuana Growers and Sellers
  • Accounting
  • Payroll
  • Cash Flow Management
  • Tax Payments
  • Security
  • Laboratory Testing
  • AND Capital for Expansion or Acquisitions
  • In Exchange GREEN will receive a variable rate contract loosely based upon an agreed upon % of sales
  • $1 million invested properly should return approx. $500k in yr 1; $1 million yr 2, $2 million yr 3

Dc Capital Structure

  • 3.8 Billion Shares currently outstanding
  • 5 Billion Common shares authorized
  • 14-C Definitive filed June 6, 2014 increasing authorized to 30 Billion effective June 29, 2014
  • Series A Preferred Stock provides 51.25% voting control – owned by Bob Armstrong CEO
  • Series B –G Preferred Stock convertible into approx. 30% of the company
  • $1 million Senior Secured Debt secured by all assets of DC held by Richard Pearce – former CEO
  • $5 million of unsecured debt (approx.) held by 40 lenders

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , ,

EXEO Entertainment Inc – EXEO


Headquartered in Las Vegas, Nevada Exeo Entertainment, Inc. is public company listed on the OTCBB and traded under the symbol “EXEO.” They develop, acquire, manufacture, license and distribute unique products in the video gaming, music, and smart TV sectors.

Exeo markets its products under the following brands: Psyko™ Audio, Krankz™ Audio, Zaaz™ keyboards, and the Extreme Gamer®. They seek to develop, license, and distribute products within the interactive entertainment sector that fill a clearly defined need and provide above average shareholder returns.

They began operations in May 2011 when they executed a license agreement with Digital Extreme Technologies, Inc. to complete product development and commercialization on the Extreme Gamer®, the Zaaz™ keyboard, and the portable gaming system. In 2013 they executed a license agreement with Psyko Audio Labs Canada to market the patented Psyko Krypton & Carbon 5.1 gaming headphones.

They are currently working on securing distribution and making the products available to consumers through big box retailers.

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , ,

Gold Hill Resources – GULD


Gold Hill Resources, Inc. is a precious metals mining and technology company headquartered in Las Vegas, Nevada. They own and operate two wholly owned subsidiaries called Accurate Locators in Gold Hill, Oregon and Imaging Locators in Pahrump, Nevada. Accurate is a leading developer of metal and underground detection systems that has been in business since 1992. Our research, development and demonstration facilities is managed through Imaging Locators.

Gold Hill Resources has The Micro Gold Mine Claim which is located in Jackson County, Oregon on a 20-acre parcel of land within the Gold Hill Mining District and they also own a claim called GHR 1 adjacent to the Johnny/Labbe Mines near Pahrump, Nevada.

Micro Gold Mine Claim

The Micro Gold Mine Claim is located in Jackson County, Oregon on a 20-acre parcel of land within the Gold Hill Mining District. The land has significant tailings with very high gold ore content. This property was acquired as part of the acquisition of Accurate Locators as a wholly owned subsidiary of Gold Hill Resources.

The Gold Hill Mining District, where the Micro Gold Mine Claim is located has excellent potential and is known for its high-grade gold pockets ranging in size from 50 oz to 8000 oz each. These pockets have been very easy to extract because the gold is typically concentrated in one small location. There have been 500 oz gold deposits have been found in a drum size area. Initial exploration and low scale mining can be begin with minimum regulatory hurdles. They plan to do further analysis, verification and exploration before commencing any excavation on the claim.

GHR 1 Mine Claim

The Company also owns a claim called GHR 1 adjacent to the Johnny/Labbe Mines near Pahrump, Nevada. The claim includes an underground shaft and tunnel located in the same gold vein as the Johnny/Labbe Mine extension. This claim has been extensively surveyed by Mr. Good and his team. During early exploration, their team determined that there was significant gold ore deposits may be present but have not been worked because the deposit fell in between the Johnny Mine and Libbe Mine. This ore deposit that may be present is next to the main fault about 20 feet to the east.

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Strategic Global Investments, Inc. – STBV


Strategic Global Investments provides live streaming video content and related digital advertising via its websites and social media. The company’s online business is divided into the two segments—WaZillo, and WaZilloMedia—as summarized on the right.

The convergence of a number of key social, technical, and economic factors are driving the market and making this the right time for Strategic’s online solutions.

Video: There is no question that online video continues to boom. According to Internet audience measurement firm comScore Media Metrix, video watching now accounts for approximately one-eighth of Americans’ total time spent on the Internet.

Broadband: A key driver for streaming video has been broadband access, which has been rapidly adopted over the past ten years. More than 85% of all Americans now use broadband access from their homes.

Mobile Connectivity: The growth in mobile media usage is largely attributable to the growth in smartphone adoption, 3G/4G device ownership and the increasing ubiquity of unlimited data plans, all of which facilitate the consumption of mobile media.

Search: Online it’s easy to find information. Major search engines are among the most heavily trafficked sites on the Web. People are increasingly turning to the Web—and not solely search engines—as their source of information for making decisions of all types.

Immediacy: Sparked by Facebook and Twitter, the real-time trend represents the growing demand for immediacy in people’s activities and interactions. Immediacy is compelling, engaging, and highly addictive—it’s a sense of living in the now.

Demographics: Adults in their twenties and thirties are the most socially active age group. They like to go out to meet new people, socialize with their friends, people watch, and dance. In the U.S. 27% of the population is between the ages of twenty and forty—82.9 million people in total.

The expectation of real-time, on demand information is becoming a part of every aspect of people’s lives. Strategic Global Investments is positioned to benefit as people’s focus and purchasing dollars continue to shift to online resources.

Company Website;

http://www.StrategicGlobalInvestments.net

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , ,

Green Parts International Inc – GNPT


Green Parts International is a recycler of automobiles and appliances providing raw materials for manufactures in the United States, China, Korea, and India. By separating the different materials and parts and shipping them to the end users Green Parts maximizes the effectiveness of the recycling efforts. Parts from cars and office equipment are reused and do not end up in landfills.

By utilizing state of the art recycling equipment the parts not suitable for reuse are broken down to their base elements and sold as raw materials for manufacturing. These materials include steel, aluminum, and copper. Automotive oils and greases are also recovered and recycled. This “green” approach to total recycling is not only good for the environment but also offers tremendous profit potential.

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Readen Holding Corp – RHCO


Readen Holding Corp, a Venture Capital organisation,investor and shareholder of companies operating in hree separate industries. Readen Holding Corp. has access to an extensive, influential and loyal network of business relations and investors.

Readen Group’s mission statement is to be a valuable partner for customers in terms of technical flexibility, quality and competitive pricing through the complete value chain (SIM cards, mobile phones and applications).

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , ,

Arrayit – ARYC


Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit’s worldwide business position leverages the company’s widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy

Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries. Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene’ Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and theSilicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company’s products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Medient Studios, Inc. (OTCQB: MDNT)


Medient Studios, Inc. (OTCQB: MDNT) is an entertainment content creation company with a strong presence in North America, Europe and India. Medient’s management team has approximately 150 years of experience in the motion picture industry and is responsible for producing and/or financing over 250 movies. Medient is realigning the content creation process to enable efficiencies of scale and eliminate process waste by building a fully integrated movie and game production facility and campus on a 1550 acre property in Effingham County, Georgia. Once operational this production facility will be the largest of its kind in the United States.

The Company has produced a broad spectrum of films across various genres. These include such films as “Bombay Boys”, a genre-defining Indie film that carried Indian cinema beyond the “song and dance” routine of Bollywood, and the award-winning Malayalam film “Aakshagopuram”, which was the first Indian film to be entirely produced outside of that country. The film, which bought together talent from India and the UK, set a new benchmark in East – West collaboration. “Storage 24″, a British horror film starring BAFTA award winner Noel Clarke was produced by Medient and released in 2012 by Universal Pictures.

Medient’s latest film, “Yellow”, is directed by Nick Cassavetes (The Notebook) and premiered to rave reviews and audience acclaim at the 2012 Toronto International Film Festival (“TIFF”). Critic reviews from TIFF included “surreal imagination”…”bizarre parallel realities”…”wildly inventive”…and “a cinematic trip of mind-bending proportions”.

Posted in Featured, Stock NewsComments Off

Advertise Here